# C_2011008EN.01000701.xml

| 13.1.2011 | EN | Official Journal of the European Union | C 8/7 |
| --- | --- | --- | --- |

13.1.2011

EN

Official Journal of the European Union

C 8/7

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2010

2011/C 8/07

Subcommittee I on the free movement of goods

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2010, at their meeting on 1 October 2010:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

List of new marketing authorisations

Annex II

List of renewed marketing authorisations

Annex III

List of extended marketing authorisations

Annex IV

List of withdrawn marketing authorisations

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2010:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/367/001/NO-012/NO | Diacomit | Norway | 5.2.2010 |
| EU/1/08/476/005-006 | Adcirca | Liechtenstein | 28.2.2010 |
| EU/1/09/571/001/IS | Pandemic Influenza Vaccine H5N1 Baxter | Iceland | 27.1.2010 |
| EU/1/09/577/001/NO-004/NO | Foclivia | Norway | 18.2.2010 |
| EU/1/09/583/001/NO-072/NO | Irbesartan/Hydrochlorothiazide Teva | Norway | 18.1.2010 |
| EU/1/09/583/001-072 | Irbesartan/Hydrochlorothiazide Teva | Liechtenstein | 28.2.2010 |
| EU/1/09/584/001-018 | Sildenafil Teva | Liechtenstein | 28.2.2010 |
| EU/1/09/585/001/NO-018/NO | Rivastigmine 1A | Norway | 9.3.2010 |
| EU/1/09/585/001-018/IS | Rivastigmine 1A | Iceland | 2.3.2010 |
| EU/1/09/586/001/NO-010/NO | Oslif Breezhaler | Norway | 27.1.2010 |
| EU/1/09/586/001-010 | Oslif Breezhaler | Liechtenstein | 28.2.2010 |
| EU/1/09/587/001/NO-017/NO | Olanzapine Glenmark | Norway | 3.2.2010 |
| EU/1/09/587/001-017 | Olanzapine Glenmark | Liechtenstein | 28.2.2010 |
| EU/1/09/587/001-017/IS | Olanzapine Glenmark | Iceland | 25.1.2010 |
| EU/1/09/588/001/NO-012/NO | Olanzapine Glenmark Europe | Norway | 6.2.2010 |
| EU/1/09/588/001-012 | Olanzapine Glenmark Europe | Liechtenstein | 28.2.2010 |
| EU/1/09/588/001-012/IS | Olanzapine Glenmark Europe | Iceland | 25.1.2010 |
| EU/1/09/589/001/NO-018/NO | Rivastigmine Hexal | Norway | 9.3.2010 |
| EU/1/09/589/001-018 | Rivastigmine Hexal | Liechtenstein | 28.2.2010 |
| EU/1/09/589/001-018/IS | Rivastigmine Hexal | Iceland | 4.3.2010 |
| EU/1/09/590/001/NO-006/NO | Prevenar 13 | Norway | 18.1.2010 |
| EU/1/09/590/001-006 | Prevenar 13 | Liechtenstein | 28.2.2010 |
| EU/1/09/592/001/NO-005/NO | Olazax Disperzi | Norway | 4.2.2010 |
| EU/1/09/592/001-005 | Olazax Disperzi | Liechtenstein | 28.2.2010 |
| EU/1/09/592/001-005/IS | Olazax Disperzi | Iceland | 25.1.2010 |
| EU/1/09/593/001/NO-010/NO | Onbrez Breezhaler | Norway | 6.1.2010 |
| EU/1/09/593/001-010 | Onbrez Breezhaler | Liechtenstein | 28.2.2010 |
| EU/1/09/594/001/NO-010/NO | Hirobriz Breezhaler | Norway | 28.1.2010 |
| EU/1/09/594/001-010 | Hirobriz Breezhaler | Liechtenstein | 28.2.2010 |
| EU/1/09/595/001/NO-015/NO | Sildenafil Actavis | Norway | 13.1.2010 |
| EU/1/09/595/001-015/IS | Sildenafil Actavis | Iceland | 7.1.2010 |
| EU/1/09/596/001/NO-014/NO | Lamuvidine Teva Pharma BV | Norway | 11.1.2010 |
| EU/1/09/596/001-014 | Lamivudine Teva Pharma BV | Liechtenstein | 28.2.2010 |
| EU/1/09/596/001-014/IS | Lamivudine Teva Pharma BV | Iceland | 1.3.2010 |
| EU/1/09/597/001/NO-005/NO | Olazax | Norway | 4.2.2010 |
| EU/1/09/597/001-005/IS | Olazax | Iceland | 25.1.2010 |
| EU/1/09/598/001/NO-004/NO | Nevirapine Teva | Norway | 11.1.2010 |
| EU/1/09/598/001-004/IS | Nevirapine Teva | Iceland | 1.3.2010 |
| EU/1/09/599/001/NO-018/NO | Rivastigmine Sandoz | Norway | 9.3.2010 |
| EU/1/09/599/001-018/IS | Rivastigmine Sandoz | Iceland | 4.3.2010 |
| EU/1/09/600/001/IS | Zutectra | Iceland | 24.2.2010 |
| EU/1/09/600/001/NO | Zutectra | Norway | 11.1.2010 |
| EU/1/09/601/001 | Zenas | Liechtenstein | 28.2.2010 |
| EU/1/09/601/001/NO | Zenas | Norway | 4.2.2010 |
| EU/1/09/601/001/IS | Zenas | Iceland | 20.1.2010 |
| EU/1/09/602/001/NO-002/NO | Scintimun | Norway | 25.1.2010 |
| EU/1/09/602/001-002 | Scintimun | Liechtenstein | 28.2.2010 |
| EU/1/09/602/001-002/IS | Scintimun | Iceland | 21.1.2010 |
| EU/1/09/603/001/NO-012/NO | Sildenafil ratiopharm | Norway | 13.1.2010 |
| EU/1/09/603/001-012 | Sildenafil ratiopharm | Liechtenstein | 28.2.2010 |
| EU/1/09/603/001-012/IS | Sildenafil ratiopharm | Iceland | 18.1.2010 |
| EU/1/09/604/001/NO-010/NO | Leflunomide Winthrop | Norway | 4.2.2010 |
| EU/1/09/604/001-010 | Leflunomide Winthrop | Liechtenstein | 28.2.2010 |
| EU/1/09/604/001-010/IS | Leflunomide Winthrop | Iceland | 22.1.2010 |
| EU/1/09/605/001-012 | Temomedac | Liechtenstein | 28.2.2010 |
| EU/1/09/605/001-012/IS | Temomedac | Iceland | 24.2.2010 |
| EU/1/09/606/001/NO-012/NO | Temozolomide | Norway | 15.2.2010 |
| EU/1/09/606/001-012 | Temozolomide | Liechtenstein | 28.2.2010 |
| EU/1/09/606/001-012/IS | Temozolomide | Iceland | 16.2.2010 |
| EU/1/09/607/001/NO-014/NO | Silodyx | Norway | 9.2.2010 |
| EU/1/09/607/001-014 | Silodyx | Liechtenstein | 28.2.2010 |
| EU/1/09/607/001-014/IS | Silodyx | Iceland | 16.3.2010 |
| EU/1/09/608/001/NO-014/NO | Urorec | Norway | 9.2.2010 |
| EU/1/09/608/001-014 | Urorec | Liechtenstein | 28.2.2010 |
| EU/1/09/608/001-014/IS | Urorec | Iceland | 16.3.2010 |
| EU/1/09/609/001/NO-002/NO | Elonva | Norway | 11.3.2010 |
| EU/1/09/609/001-002 | Elonva | Liechtenstein | 28.2.2010 |
| EU/1/09/609/001-002/IS | Elonva | Iceland | 10.2.2010 |
| EU/1/09/610/001/NO-030/NO | Telmisartan Teva | Norway | 2.3.2010 |
| EU/1/09/610/001-030 | Telmisartan Teva | Liechtenstein | 28.2.2010 |
| EU/1/09/610/001-030/IS | Telmisartan Teva | Iceland | 16.3.2010 |
| EU/1/09/611/001/NO-002/NO | Docetaxel Teva | Norway | 26.2.2010 |
| EU/1/09/611/001-002 | Docetaxel Teva | Liechtenstein | 28.2.2010 |
| EU/1/09/611/001-002/IS | Docetaxel Teva | Iceland | 23.2.2010 |
| EU/1/10/612/001/NO-006/NO | Revolade | Norway | 25.3.2010 |
| EU/1/10/612/001-006 | Revolade | Liechtenstein | 30.4.2010 |
| EU/1/10/612/001-006/IS | Revolade | Iceland | 7.4.2010 |
| EU/1/10/613/001/NO-002/NO | ImmunoGam | Norway | 19.4.2010 |
| EU/1/10/613/001-002 | ImmunoGam | Liechtenstein | 30.4.2010 |
| EU/1/10/613/001-002/IS | ImmunoGam | Iceland | 28.4.2010 |
| EU/1/10/614/001 | Menveo | Liechtenstein | 30.4.2010 |
| EU/1/10/614/001/IS | Menveo | Iceland | 15.6.2010 |
| EU/1/10/614/001/NO | Menveo | Norway | 21.4.2010 |
| EU/1/10/615/001/NO-024/NO | Temozolomide Hospira | Norway | 24.3.2010 |
| EU/1/10/615/001-024 | Temozolomide Hospira | Liechtenstein | 30.4.2010 |
| EU/1/10/615/001-024/IS | Temozolomide Hospira | Iceland | 3.5.2010 |
| EU/1/10/616/001/NO-024/NO | Temozolomide Hexal | Norway | 26.4.2010 |
| EU/1/10/616/001-024 | Temozolomide Hexal | Liechtenstein | 30.4.2010 |
| EU/1/10/616/001-024/IS | Temozolomide Hexal | Iceland | 27.4.2010 |
| EU/1/10/617/001/NO-024/NO | Temozolomide Sandoz | Norway | 26.4.2010 |
| EU/1/10/617/001-024 | Temozolomide Sandoz | Liechtenstein | 30.4.2010 |
| EU/1/10/617/001-024/IS | Temozolomide Sandoz | Iceland | 27.4.2010 |
| EU/1/10/618/001-004 | Prolia | Liechtenstein | 30.6.2010 |
| EU/1/10/618/001-004/IS | Prolia | Iceland | 23.6.2010 |
| EU/1/10/619/001/NO-014/NO | DuoPlavin | Norway | 23.3.2010 |
| EU/1/10/619/001-014 | DuoPlavin | Liechtenstein | 30.4.2010 |
| EU/1/10/619/001-014/IS | DuoPlavin | Iceland | 21.4.2010 |
| EU/1/10/620/001/NO-016/NO | Ristfor | Norway | 3.6.2010 |
| EU/1/10/620/001-016 | Ristfor | Liechtenstein | 30.4.2010 |
| EU/1/10/620/001-016/IS | Ristfor | Iceland | 5.5.2010 |
| EU/1/10/621/001/NO-018/NO | Ristaben | Norway | 3.6.2010 |
| EU/1/10/621/001-018 | Ristaben | Liechtenstein | 30.4.2010 |
| EU/1/10/621/001-018/IS | Ristaben | Iceland | 5.5.2010 |
| EU/1/10/622/001/NO-002/NO | Tepadina | Norway | 25.3.2010 |
| EU/1/10/622/001-002/IS | Tepadina | Iceland | 21.4.2010 |
| EU/1/10/622/001-002 | Tepadina | Liechtenstein | 30.4.2010 |
| EU/1/10/623/001/NO-014/NO | DuoCover | Norway | 23.3.2010 |
| EU/1/10/623/001-014 | DuoCover | Liechtenstein | 30.4.2010 |
| EU/1/10/623/001-014/IS | DuoCover | Iceland | 21.4.2010 |
| EU/1/10/624/001 | Arepanrix | Liechtenstein | 30.4.2010 |
| EU/1/10/624/001/IS | Arepanrix | Iceland | 21.5.2010 |
| EU/1/10/625/001/NO-002/NO | Arzerra | Norway | 12.5.2010 |
| EU/1/10/625/001-002 | Arzerra | Liechtenstein | 30.4.2010 |
| EU/1/10/625/001-002/IS | Arzerra | Iceland | 17.5.2010 |
| EU/1/10/626/001/NO-004/NO | Ribavirin BioPartners | Norway | 22.4.2010 |
| EU/1/10/626/001-004/IS | Ribavirin BioPartners | Iceland | 17.5.2010 |
| EU/1/10/627/001/NO-003/NO | Raloxifene Teva | Norway | 31.5.2010 |
| EU/1/10/627/001-003 | Raloxifene Teva | Liechtenstein | 30.4.2010 |
| EU/1/10/627/001-003/IS | Raloxifene Teva | Iceland | 18.6.2010 |
| EU/1/10/628/001/NO-004/NO | Votrient | Norway | 28.6.2010 |
| EU/1/10/628/001-004 | Votrient | Liechtenstein | 30.6.2010 |
| EU/1/10/628/001-004/IS | Votrient | Iceland | 28.6.2010 |
| EU/1/10/629/001 | Humenza | Liechtenstein | 30.6.2010 |
| EU/1/10/629/001/IS | Humenza | Iceland | 28.6.2010 |
| EU/1/10/630/001/NO-002/NO | Docefrez | Norway | 7.6.2010 |
| EU/1/10/630/001-002 | Docefrez | Liechtenstein | 30.6.2010 |
| EU/1/10/630/001-002/IS | Docefrez | Iceland | 29.6.2010 |
| EU/1/10/631/001-009 | Nivestim | Liechtenstein | 30.6.2010 |
| EU/1/10/632/001-021 | Tolura | Liechtenstein | 30.6.2010 |
| EU/1/10/633/001/NO-002/NO | Topotecan Hospira | Norway | 22.6.2010 |
| EU/1/10/633/001-002 | Topotecan Hospira | Liechtenstein | 30.6.2010 |
| EU/1/10/634/001-004 | Ribaverin Three Rivers | Liechtenstein | 30.6.2010 |
| EU/1/10/634/001-004/IS | Ribavirin Three Rivers | Iceland | 28.6.2010 |
| EU/1/10/635/001-014 | Olanzapine Apotex | Liechtenstein | 30.6.2010 |
| EU/1/10/635/001-014/IS | Olanzapine Apotex | Iceland | 28.6.2010 |
| EU/2/08/085/001/NO | Easotic | Norway | 4.5.2010 |
| EU/2/08/090/001-008/IS | Loxicom | Iceland | 23.2.2010 |
| EU/2/09/096/001/NO-002/NO | Leucogen | Norway | 8.2.2010 |
| EU/2/09/101/001/NO-010/NO | Zolvix | Norway | 8.2.2010 |
| EU/2/09/101/001-010/IS | Zolvix | Iceland | 4.3.2010 |
| EU/2/09/102/001/NO-006/NO | Gripovac 3 | Norway | 21.4.2010 |
| EU/2/09/102/001-006 | Gripovac 3 | Liechtenstein | 28.2.2010 |
| EU/2/09/102/001-006/IS | Gripovac 3 | Iceland | 4.3.2010 |
| EU/2/09/103/001-006 | Respiporc FLU3 | Liechtenstein | 28.2.2010 |
| EU/2/09/103/001-006/IS | Respiporc FLU3 | Iceland | 4.3.2010 |
| EU/2/09/104/001/NO-002/NO | Zulvac 8 Ovis | Norway | 11.2.2010 |
| EU/2/09/104/001-002 | Zulvac 8 Ovis | Liechtenstein | 28.2.2010 |
| EU/2/09/104/001-002/IS | Zulvac 8 Ovis | Iceland | 28.1.2010 |
| EU/2/09/105/001/NO-002/NO | Zulvac 8 Bovis | Norway | 8.2.2010 |
| EU/2/09/105/001-002 | Zulvac 8 Bovis | Liechtenstein | 28.2.2010 |
| EU/2/09/105/001-002/IS | Zulvac 8 Bovis | Iceland | 27.1.2010 |

EU-Number

Product

Country

Date of authorisation

EU/1/06/367/001/NO-012/NO

Diacomit

Norway

5.2.2010

EU/1/08/476/005-006

Adcirca

Liechtenstein

28.2.2010

EU/1/09/571/001/IS

Pandemic Influenza Vaccine H5N1 Baxter

Iceland

27.1.2010

EU/1/09/577/001/NO-004/NO

Foclivia

Norway

18.2.2010

EU/1/09/583/001/NO-072/NO

Irbesartan/Hydrochlorothiazide Teva

Norway

18.1.2010

EU/1/09/583/001-072

Irbesartan/Hydrochlorothiazide Teva

Liechtenstein

28.2.2010

EU/1/09/584/001-018

Sildenafil Teva

Liechtenstein

28.2.2010

EU/1/09/585/001/NO-018/NO

Rivastigmine 1A

Norway

9.3.2010

EU/1/09/585/001-018/IS

Rivastigmine 1A

Iceland

2.3.2010

EU/1/09/586/001/NO-010/NO

Oslif Breezhaler

Norway

27.1.2010

EU/1/09/586/001-010

Oslif Breezhaler

Liechtenstein

28.2.2010

EU/1/09/587/001/NO-017/NO

Olanzapine Glenmark

Norway

3.2.2010

EU/1/09/587/001-017

Olanzapine Glenmark

Liechtenstein

28.2.2010

EU/1/09/587/001-017/IS

Olanzapine Glenmark

Iceland

25.1.2010

EU/1/09/588/001/NO-012/NO

Olanzapine Glenmark Europe

Norway

6.2.2010

EU/1/09/588/001-012

Olanzapine Glenmark Europe

Liechtenstein

28.2.2010

EU/1/09/588/001-012/IS

Olanzapine Glenmark Europe

Iceland

25.1.2010

EU/1/09/589/001/NO-018/NO

Rivastigmine Hexal

Norway

9.3.2010

EU/1/09/589/001-018

Rivastigmine Hexal

Liechtenstein

28.2.2010

EU/1/09/589/001-018/IS

Rivastigmine Hexal

Iceland

4.3.2010

EU/1/09/590/001/NO-006/NO

Prevenar 13

Norway

18.1.2010

EU/1/09/590/001-006

Prevenar 13

Liechtenstein

28.2.2010

EU/1/09/592/001/NO-005/NO

Olazax Disperzi

Norway

4.2.2010

EU/1/09/592/001-005

Olazax Disperzi

Liechtenstein

28.2.2010

EU/1/09/592/001-005/IS

Olazax Disperzi

Iceland

25.1.2010

EU/1/09/593/001/NO-010/NO

Onbrez Breezhaler

Norway

6.1.2010

EU/1/09/593/001-010

Onbrez Breezhaler

Liechtenstein

28.2.2010

EU/1/09/594/001/NO-010/NO

Hirobriz Breezhaler

Norway

28.1.2010

EU/1/09/594/001-010

Hirobriz Breezhaler

Liechtenstein

28.2.2010

EU/1/09/595/001/NO-015/NO

Sildenafil Actavis

Norway

13.1.2010

EU/1/09/595/001-015/IS

Sildenafil Actavis

Iceland

7.1.2010

EU/1/09/596/001/NO-014/NO

Lamuvidine Teva Pharma BV

Norway

11.1.2010

EU/1/09/596/001-014

Lamivudine Teva Pharma BV

Liechtenstein

28.2.2010

EU/1/09/596/001-014/IS

Lamivudine Teva Pharma BV

Iceland

1.3.2010

EU/1/09/597/001/NO-005/NO

Olazax

Norway

4.2.2010

EU/1/09/597/001-005/IS

Olazax

Iceland

25.1.2010

EU/1/09/598/001/NO-004/NO

Nevirapine Teva

Norway

11.1.2010

EU/1/09/598/001-004/IS

Nevirapine Teva

Iceland

1.3.2010

EU/1/09/599/001/NO-018/NO

Rivastigmine Sandoz

Norway

9.3.2010

EU/1/09/599/001-018/IS

Rivastigmine Sandoz

Iceland

4.3.2010

EU/1/09/600/001/IS

Zutectra

Iceland

24.2.2010

EU/1/09/600/001/NO

Zutectra

Norway

11.1.2010

EU/1/09/601/001

Zenas

Liechtenstein

28.2.2010

EU/1/09/601/001/NO

Zenas

Norway

4.2.2010

EU/1/09/601/001/IS

Zenas

Iceland

20.1.2010

EU/1/09/602/001/NO-002/NO

Scintimun

Norway

25.1.2010

EU/1/09/602/001-002

Scintimun

Liechtenstein

28.2.2010

EU/1/09/602/001-002/IS

Scintimun

Iceland

21.1.2010

EU/1/09/603/001/NO-012/NO

Sildenafil ratiopharm

Norway

13.1.2010

EU/1/09/603/001-012

Sildenafil ratiopharm

Liechtenstein

28.2.2010

EU/1/09/603/001-012/IS

Sildenafil ratiopharm

Iceland

18.1.2010

EU/1/09/604/001/NO-010/NO

Leflunomide Winthrop

Norway

4.2.2010

EU/1/09/604/001-010

Leflunomide Winthrop

Liechtenstein

28.2.2010

EU/1/09/604/001-010/IS

Leflunomide Winthrop

Iceland

22.1.2010

EU/1/09/605/001-012

Temomedac

Liechtenstein

28.2.2010

EU/1/09/605/001-012/IS

Temomedac

Iceland

24.2.2010

EU/1/09/606/001/NO-012/NO

Temozolomide

Norway

15.2.2010

EU/1/09/606/001-012

Temozolomide

Liechtenstein

28.2.2010

EU/1/09/606/001-012/IS

Temozolomide

Iceland

16.2.2010

EU/1/09/607/001/NO-014/NO

Silodyx

Norway

9.2.2010

EU/1/09/607/001-014

Silodyx

Liechtenstein

28.2.2010

EU/1/09/607/001-014/IS

Silodyx

Iceland

16.3.2010

EU/1/09/608/001/NO-014/NO

Urorec

Norway

9.2.2010

EU/1/09/608/001-014

Urorec

Liechtenstein

28.2.2010

EU/1/09/608/001-014/IS

Urorec

Iceland

16.3.2010

EU/1/09/609/001/NO-002/NO

Elonva

Norway

11.3.2010

EU/1/09/609/001-002

Elonva

Liechtenstein

28.2.2010

EU/1/09/609/001-002/IS

Elonva

Iceland

10.2.2010

EU/1/09/610/001/NO-030/NO

Telmisartan Teva

Norway

2.3.2010

EU/1/09/610/001-030

Telmisartan Teva

Liechtenstein

28.2.2010

EU/1/09/610/001-030/IS

Telmisartan Teva

Iceland

16.3.2010

EU/1/09/611/001/NO-002/NO

Docetaxel Teva

Norway

26.2.2010

EU/1/09/611/001-002

Docetaxel Teva

Liechtenstein

28.2.2010

EU/1/09/611/001-002/IS

Docetaxel Teva

Iceland

23.2.2010

EU/1/10/612/001/NO-006/NO

Revolade

Norway

25.3.2010

EU/1/10/612/001-006

Revolade

Liechtenstein

30.4.2010

EU/1/10/612/001-006/IS

Revolade

Iceland

7.4.2010

EU/1/10/613/001/NO-002/NO

ImmunoGam

Norway

19.4.2010

EU/1/10/613/001-002

ImmunoGam

Liechtenstein

30.4.2010

EU/1/10/613/001-002/IS

ImmunoGam

Iceland

28.4.2010

EU/1/10/614/001

Menveo

Liechtenstein

30.4.2010

EU/1/10/614/001/IS

Menveo

Iceland

15.6.2010

EU/1/10/614/001/NO

Menveo

Norway

21.4.2010

EU/1/10/615/001/NO-024/NO

Temozolomide Hospira

Norway

24.3.2010

EU/1/10/615/001-024

Temozolomide Hospira

Liechtenstein

30.4.2010

EU/1/10/615/001-024/IS

Temozolomide Hospira

Iceland

3.5.2010

EU/1/10/616/001/NO-024/NO

Temozolomide Hexal

Norway

26.4.2010

EU/1/10/616/001-024

Temozolomide Hexal

Liechtenstein

30.4.2010

EU/1/10/616/001-024/IS

Temozolomide Hexal

Iceland

27.4.2010

EU/1/10/617/001/NO-024/NO

Temozolomide Sandoz

Norway

26.4.2010

EU/1/10/617/001-024

Temozolomide Sandoz

Liechtenstein

30.4.2010

EU/1/10/617/001-024/IS

Temozolomide Sandoz

Iceland

27.4.2010

EU/1/10/618/001-004

Prolia

Liechtenstein

30.6.2010

EU/1/10/618/001-004/IS

Prolia

Iceland

23.6.2010

EU/1/10/619/001/NO-014/NO

DuoPlavin

Norway

23.3.2010

EU/1/10/619/001-014

DuoPlavin

Liechtenstein

30.4.2010

EU/1/10/619/001-014/IS

DuoPlavin

Iceland

21.4.2010

EU/1/10/620/001/NO-016/NO

Ristfor

Norway

3.6.2010

EU/1/10/620/001-016

Ristfor

Liechtenstein

30.4.2010

EU/1/10/620/001-016/IS

Ristfor

Iceland

5.5.2010

EU/1/10/621/001/NO-018/NO

Ristaben

Norway

3.6.2010

EU/1/10/621/001-018

Ristaben

Liechtenstein

30.4.2010

EU/1/10/621/001-018/IS

Ristaben

Iceland

5.5.2010

EU/1/10/622/001/NO-002/NO

Tepadina

Norway

25.3.2010

EU/1/10/622/001-002/IS

Tepadina

Iceland

21.4.2010

EU/1/10/622/001-002

Tepadina

Liechtenstein

30.4.2010

EU/1/10/623/001/NO-014/NO

DuoCover

Norway

23.3.2010

EU/1/10/623/001-014

DuoCover

Liechtenstein

30.4.2010

EU/1/10/623/001-014/IS

DuoCover

Iceland

21.4.2010

EU/1/10/624/001

Arepanrix

Liechtenstein

30.4.2010

EU/1/10/624/001/IS

Arepanrix

Iceland

21.5.2010

EU/1/10/625/001/NO-002/NO

Arzerra

Norway

12.5.2010

EU/1/10/625/001-002

Arzerra

Liechtenstein

30.4.2010

EU/1/10/625/001-002/IS

Arzerra

Iceland

17.5.2010

EU/1/10/626/001/NO-004/NO

Ribavirin BioPartners

Norway

22.4.2010

EU/1/10/626/001-004/IS

Ribavirin BioPartners

Iceland

17.5.2010

EU/1/10/627/001/NO-003/NO

Raloxifene Teva

Norway

31.5.2010

EU/1/10/627/001-003

Raloxifene Teva

Liechtenstein

30.4.2010

EU/1/10/627/001-003/IS

Raloxifene Teva

Iceland

18.6.2010

EU/1/10/628/001/NO-004/NO

Votrient

Norway

28.6.2010

EU/1/10/628/001-004

Votrient

Liechtenstein

30.6.2010

EU/1/10/628/001-004/IS

Votrient

Iceland

28.6.2010

EU/1/10/629/001

Humenza

Liechtenstein

30.6.2010

EU/1/10/629/001/IS

Humenza

Iceland

28.6.2010

EU/1/10/630/001/NO-002/NO

Docefrez

Norway

7.6.2010

EU/1/10/630/001-002

Docefrez

Liechtenstein

30.6.2010

EU/1/10/630/001-002/IS

Docefrez

Iceland

29.6.2010

EU/1/10/631/001-009

Nivestim

Liechtenstein

30.6.2010

EU/1/10/632/001-021

Tolura

Liechtenstein

30.6.2010

EU/1/10/633/001/NO-002/NO

Topotecan Hospira

Norway

22.6.2010

EU/1/10/633/001-002

Topotecan Hospira

Liechtenstein

30.6.2010

EU/1/10/634/001-004

Ribaverin Three Rivers

Liechtenstein

30.6.2010

EU/1/10/634/001-004/IS

Ribavirin Three Rivers

Iceland

28.6.2010

EU/1/10/635/001-014

Olanzapine Apotex

Liechtenstein

30.6.2010

EU/1/10/635/001-014/IS

Olanzapine Apotex

Iceland

28.6.2010

EU/2/08/085/001/NO

Easotic

Norway

4.5.2010

EU/2/08/090/001-008/IS

Loxicom

Iceland

23.2.2010

EU/2/09/096/001/NO-002/NO

Leucogen

Norway

8.2.2010

EU/2/09/101/001/NO-010/NO

Zolvix

Norway

8.2.2010

EU/2/09/101/001-010/IS

Zolvix

Iceland

4.3.2010

EU/2/09/102/001/NO-006/NO

Gripovac 3

Norway

21.4.2010

EU/2/09/102/001-006

Gripovac 3

Liechtenstein

28.2.2010

EU/2/09/102/001-006/IS

Gripovac 3

Iceland

4.3.2010

EU/2/09/103/001-006

Respiporc FLU3

Liechtenstein

28.2.2010

EU/2/09/103/001-006/IS

Respiporc FLU3

Iceland

4.3.2010

EU/2/09/104/001/NO-002/NO

Zulvac 8 Ovis

Norway

11.2.2010

EU/2/09/104/001-002

Zulvac 8 Ovis

Liechtenstein

28.2.2010

EU/2/09/104/001-002/IS

Zulvac 8 Ovis

Iceland

28.1.2010

EU/2/09/105/001/NO-002/NO

Zulvac 8 Bovis

Norway

8.2.2010

EU/2/09/105/001-002

Zulvac 8 Bovis

Liechtenstein

28.2.2010

EU/2/09/105/001-002/IS

Zulvac 8 Bovis

Iceland

27.1.2010

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2010:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/129/001-003 | Azopt | Liechtenstein | 28.2.2010 |
| EU/1/00/129/001-003/IS | Azopt | Iceland | 16.3.2010 |
| EU/1/00/130/001/NO-002/NO | Orgalutran | Norway | 8.6.2010 |
| EU/1/00/130/001-002 | Orgalutran | Liechtenstein | 30.6.2010 |
| EU/1/00/130/001-002/IS | Orgalutran | Iceland | 25.6.2010 |
| EU/1/00/131/001/NO-005/NO | PegIntron | Norway | 26.5.2010 |
| EU/1/00/131/001-050 | PegIntron | Liechtenstein | 30.6.2010 |
| EU/1/00/131/001-050/IS | PegIntron | Iceland | 24.6.2010 |
| EU/1/00/132/001/NO-050/NO | ViraferonPeg | Norway | 26.5.2010 |
| EU/1/00/132/001-050 | ViraferonPeg | Liechtenstein | 30.6.2010 |
| EU/1/00/132/001-050/IS | ViraferonPeg | Iceland | 25.6.2010 |
| EU/1/00/133/001/NO-032/NO | Optisulin | Norway | 25.5.2010 |
| EU/1/00/133/001-032 | Optisulin | Liechtenstein | 30.6.2010 |
| EU/1/00/133/001-032/IS | Optisulin | Iceland | 25.6.2010 |
| EU/1/00/134/001/NO-037/NO | Lantus | Norway | 25.5.2010 |
| EU/1/00/134/001-037 | Lantus | Liechtenstein | 30.6.2010 |
| EU/1/00/134/001-037/IS | Lantus | Iceland | 25.6.2010 |
| EU/1/00/137/002/NO-018/NO | Avandia | Norway | 7.6.2010 |
| EU/1/00/137/002-012/IS | Avandia | Iceland | 18.6.2010 |
| EU/1/00/137/002-018 | Avandia | Liechtenstein | 30.6.2010 |
| EU/1/00/140/001 | Visudyne | Liechtenstein | 30.6.2010 |
| EU/1/00/140/001/IS | Visudyne | Iceland | 23.6.2010 |
| EU/1/04/272/001/NO-002/NO | PhotoBarr | Norway | 17.2.2010 |
| EU/1/04/294/001-028 | Emselex | Liechtenstein | 28.2.2010 |
| EU/1/04/298/001/NO-003/NO | Kivexa | Norway | 19.1.2010 |
| EU/1/04/298/001-003 | Kivexa | Liechtenstein | 28.2.2010 |
| EU/1/04/299/001/NO-003/NO | Fendrix | Norway | 3.2.2010 |
| EU/1/04/299/001-003 | Fendrix | Liechtenstein | 28.2.2010 |
| EU/1/04/299/001-003/IS | Fendrix | Iceland | 7.1.2010 |
| EU/1/04/300/001/NO-002/NO | Avastin | Norway | 26.1.2010 |
| EU/1/04/300/001-002 | Avastin | Liechtenstein | 28.2.2010 |
| EU/1/04/300/001-002/IS | Avastin | Iceland | 11.1.2010 |
| EU/1/04/302/001/NO-004/NO | Prialt | Norway | 8.2.2010 |
| EU/1/04/302/001-004 | Prialt | Liechtenstein | 28.2.2010 |
| EU/1/04/302/001-004/IS | Prialt | Iceland | 17.3.2010 |
| EU/1/04/303/001/NO-003 | Orfadin | Norway | 3.2.2010 |
| EU/1/04/303/001-003 | Orfadin | Liechtenstein | 28.2.2010 |
| EU/1/04/303/001-003/IS | Orfadin | Iceland | 28.1.2010 |
| EU/1/04/304/001/NO-007/NO | Azilect | Norway | 10.2.2010 |
| EU/1/04/305/001/NO-002/NO | Truvada | Norway | 3.2.2010 |
| EU/1/04/305/001-002 | Truveda | Liechtenstein | 28.2.2010 |
| EU/1/04/305/001-002/IS | Truvada | Iceland | 28.1.2010 |
| EU/1/04/306/001 | Aloxi | Liechtenstein | 30.4.2010 |
| EU/1/04/306/001/IS | Aloxi | Iceland | 11.5.2010 |
| EU/1/04/306/01/NO | Aloxi | Norway | 23.4.2010 |
| EU/1/04/307/001/NO-013/NO | Zonegran | Norway | 5.2.2010 |
| EU/1/04/307/001-013 | Zonegran | Liechtenstein | 28.2.2010 |
| EU/1/04/307/001-013/IS | Zonegran | Iceland | 13.1.2010 |
| EU/1/05/308/001/NO-002/NO | Aclasta | Norway | 23.4.2010 |
| EU/1/05/308/001-002 | Aclasta | Liechtenstein | 30.4.2010 |
| EU/1/05/308/001-002/IS | Aclasta | Iceland | 30.4.2010 |
| EU/1/06/367/001-012 | Diacomit | Liechtenstein | 28.2.2010 |
| EU/1/07/423/001-003 | Vectibix | Liechtenstein | 30.4.2010 |
| EU/1/07/423/001-003/IS | Vectibix | Iceland | 7.4.2010 |
| EU/1/07/440/001-003/IS | Tyverb | Iceland | 30.6.2010 |
| EU/1/10/618/001/NO-004/NO | Prolia | Norway | 14.6.2010 |
| EU/1/99/122/001-002 | Thyrogen | Liechtenstein | 28.2.2010 |
| EU/1/99/122/001-002/IS | Thyrogen | Iceland | 19.2.2010 |
| EU/1/99/123/005/NO-013/NO | Renagel | Norway | 14.1.2010 |
| EU/1/99/123/005-013 | Renagel | Liechtenstein | 28.2.2010 |
| EU/1/99/123/005-013/IS | Renagel | Iceland | 5.1.2010 |
| EU/1/99/124/001/NO-002/NO | Tractocile | Norway | 27.1.2010 |
| EU/1/99/124/001-002 | Tractocile | Liechtenstein | 28.2.2010 |
| EU/1/99/124/001-002/IS | Tractocile | Iceland | 18.1.2010 |
| EU/1/99/126/001/NO-021/NO | Enbrel | Norway | 14.1.2010 |
| EU/1/99/127/011/NO-044/NO | IntronA | Norway | 21.4.2010 |
| EU/1/99/127/011-039 & 041-044/IS | IntronA | Iceland | 19.4.2010 |
| EU/1/99/127/011-044 | IntronA | Liechtenstein | 30.4.2010 |
| EU/2/00/018/001 | Incurin | Liechtenstein | 30.4.2010 |
| EU/2/00/018/001/IS | Incurin | Iceland | 21.4.2010 |
| EU/2/00/018/001/NO | Incurin | Norway | 10.5.2010 |
| EU/2/00/019/005/NO-007/NO | Purevax FeLV | Norway | 10.5.2010 |
| EU/2/00/019/005-007 | Purevax FeLV | Liechtenstein | 30.4.2010 |
| EU/2/00/019/005-007/IS | Purevax FeLV | Iceland | 10.5.2010 |
| EU/2/00/021/001-002 | Rabigen SAG2 | Liechtenstein | 30.4.2010 |
| EU/2/00/021/001-002/IS | Rabigen SAG2 | Iceland | 5.5.2010 |
| EU/2/00/022/001a-001b,
  EU/2/00/022/002a-002b,
  EU/2/00/022/003a-003b,
  EU/2/022/004a-004b,
  EU/2/00/022/005-017 | Ibaflin | Liechtenstein | 30.6.2010 |
| EU/2/00/022/003-004 a+b&007-008/IS | Ibaflin | Iceland | 22.6.2010 |
| EU/2/00/022/001-002 a+b&005-006/IS | Ibaflin | Iceland | 22.6.2010 |
| EU/2/00/22/009-017/IS | Ibaflin | Iceland | 22.6.2010 |
| EU/2/04/043/001/IS | Equilis StrepE | Iceland | 14.4.2010 |
| EU/2/04/047/001/NO-002/NO | Purevax RCPCh FeLV | Norway | 24.2.2010 |
| EU/2/04/047/001-002 | Purevax RCPCh FeLV | Liechtenstein | 28.2.2010 |
| EU/2/04/047/001-002/IS | Purevax RCPCh FeLV | Iceland | 15.1.2010 |
| EU/2/04/048/001-002 | Purevax RCP FeLV | Liechtenstein | 28.2.2010 |
| EU/2/04/048/001-002/IS | Purevax RCP FeLV | Iceland | 9.2.2010 |
| EU/2/04/049/001-002 | Purevax RCCh | Liechtenstein | 28.2.2010 |
| EU/2/04/049/001-002/IS | Purevax RCCh | Iceland | 9.2.2010 |
| EU/2/04/051/001-002 | Purevax RC | Liechtenstein | 28.2.2010 |
| EU/2/04/051/001-002/IS | Purevax RC | Iceland | 9.2.2010 |
| EU/2/04/052/001-002/IS | Purevax RCP | Iceland | 9.2.2010 |
| EU/2/04/50/001-002/IS | Purevax RCPCh | Iceland | 8.2.2010 |
| EU/2/05/053/001-003 | Naxcel | Liechtenstein | 30.6.2010 |
| EU/2/99/013/001/NO-002/NO | Halocur | Norway | 26.4.2010 |
| EU/2/99/013/001-002/IS | Halocur | Iceland | 15.3.2010 |
| EU/2/99/017/001/NO-006/NO | Ibraxion | Norway | 11.5.2010 |
| EU/2/99/017/001-006/IS | Ibraxion | Iceland | 25.5.2010 |

EU-Number

Product

Country

Date of authorisation

EU/1/00/129/001-003

Azopt

Liechtenstein

28.2.2010

EU/1/00/129/001-003/IS

Azopt

Iceland

16.3.2010

EU/1/00/130/001/NO-002/NO

Orgalutran

Norway

8.6.2010

EU/1/00/130/001-002

Orgalutran

Liechtenstein

30.6.2010

EU/1/00/130/001-002/IS

Orgalutran

Iceland

25.6.2010

EU/1/00/131/001/NO-005/NO

PegIntron

Norway

26.5.2010

EU/1/00/131/001-050

PegIntron

Liechtenstein

30.6.2010

EU/1/00/131/001-050/IS

PegIntron

Iceland

24.6.2010

EU/1/00/132/001/NO-050/NO

ViraferonPeg

Norway

26.5.2010

EU/1/00/132/001-050

ViraferonPeg

Liechtenstein

30.6.2010

EU/1/00/132/001-050/IS

ViraferonPeg

Iceland

25.6.2010

EU/1/00/133/001/NO-032/NO

Optisulin

Norway

25.5.2010

EU/1/00/133/001-032

Optisulin

Liechtenstein

30.6.2010

EU/1/00/133/001-032/IS

Optisulin

Iceland

25.6.2010

EU/1/00/134/001/NO-037/NO

Lantus

Norway

25.5.2010

EU/1/00/134/001-037

Lantus

Liechtenstein

30.6.2010

EU/1/00/134/001-037/IS

Lantus

Iceland

25.6.2010

EU/1/00/137/002/NO-018/NO

Avandia

Norway

7.6.2010

EU/1/00/137/002-012/IS

Avandia

Iceland

18.6.2010

EU/1/00/137/002-018

Avandia

Liechtenstein

30.6.2010

EU/1/00/140/001

Visudyne

Liechtenstein

30.6.2010

EU/1/00/140/001/IS

Visudyne

Iceland

23.6.2010

EU/1/04/272/001/NO-002/NO

PhotoBarr

Norway

17.2.2010

EU/1/04/294/001-028

Emselex

Liechtenstein

28.2.2010

EU/1/04/298/001/NO-003/NO

Kivexa

Norway

19.1.2010

EU/1/04/298/001-003

Kivexa

Liechtenstein

28.2.2010

EU/1/04/299/001/NO-003/NO

Fendrix

Norway

3.2.2010

EU/1/04/299/001-003

Fendrix

Liechtenstein

28.2.2010

EU/1/04/299/001-003/IS

Fendrix

Iceland

7.1.2010

EU/1/04/300/001/NO-002/NO

Avastin

Norway

26.1.2010

EU/1/04/300/001-002

Avastin

Liechtenstein

28.2.2010

EU/1/04/300/001-002/IS

Avastin

Iceland

11.1.2010

EU/1/04/302/001/NO-004/NO

Prialt

Norway

8.2.2010

EU/1/04/302/001-004

Prialt

Liechtenstein

28.2.2010

EU/1/04/302/001-004/IS

Prialt

Iceland

17.3.2010

EU/1/04/303/001/NO-003

Orfadin

Norway

3.2.2010

EU/1/04/303/001-003

Orfadin

Liechtenstein

28.2.2010

EU/1/04/303/001-003/IS

Orfadin

Iceland

28.1.2010

EU/1/04/304/001/NO-007/NO

Azilect

Norway

10.2.2010

EU/1/04/305/001/NO-002/NO

Truvada

Norway

3.2.2010

EU/1/04/305/001-002

Truveda

Liechtenstein

28.2.2010

EU/1/04/305/001-002/IS

Truvada

Iceland

28.1.2010

EU/1/04/306/001

Aloxi

Liechtenstein

30.4.2010

EU/1/04/306/001/IS

Aloxi

Iceland

11.5.2010

EU/1/04/306/01/NO

Aloxi

Norway

23.4.2010

EU/1/04/307/001/NO-013/NO

Zonegran

Norway

5.2.2010

EU/1/04/307/001-013

Zonegran

Liechtenstein

28.2.2010

EU/1/04/307/001-013/IS

Zonegran

Iceland

13.1.2010

EU/1/05/308/001/NO-002/NO

Aclasta

Norway

23.4.2010

EU/1/05/308/001-002

Aclasta

Liechtenstein

30.4.2010

EU/1/05/308/001-002/IS

Aclasta

Iceland

30.4.2010

EU/1/06/367/001-012

Diacomit

Liechtenstein

28.2.2010

EU/1/07/423/001-003

Vectibix

Liechtenstein

30.4.2010

EU/1/07/423/001-003/IS

Vectibix

Iceland

7.4.2010

EU/1/07/440/001-003/IS

Tyverb

Iceland

30.6.2010

EU/1/10/618/001/NO-004/NO

Prolia

Norway

14.6.2010

EU/1/99/122/001-002

Thyrogen

Liechtenstein

28.2.2010

EU/1/99/122/001-002/IS

Thyrogen

Iceland

19.2.2010

EU/1/99/123/005/NO-013/NO

Renagel

Norway

14.1.2010

EU/1/99/123/005-013

Renagel

Liechtenstein

28.2.2010

EU/1/99/123/005-013/IS

Renagel

Iceland

5.1.2010

EU/1/99/124/001/NO-002/NO

Tractocile

Norway

27.1.2010

EU/1/99/124/001-002

Tractocile

Liechtenstein

28.2.2010

EU/1/99/124/001-002/IS

Tractocile

Iceland

18.1.2010

EU/1/99/126/001/NO-021/NO

Enbrel

Norway

14.1.2010

EU/1/99/127/011/NO-044/NO

IntronA

Norway

21.4.2010

EU/1/99/127/011-039 & 041-044/IS

IntronA

Iceland

19.4.2010

EU/1/99/127/011-044

IntronA

Liechtenstein

30.4.2010

EU/2/00/018/001

Incurin

Liechtenstein

30.4.2010

EU/2/00/018/001/IS

Incurin

Iceland

21.4.2010

EU/2/00/018/001/NO

Incurin

Norway

10.5.2010

EU/2/00/019/005/NO-007/NO

Purevax FeLV

Norway

10.5.2010

EU/2/00/019/005-007

Purevax FeLV

Liechtenstein

30.4.2010

EU/2/00/019/005-007/IS

Purevax FeLV

Iceland

10.5.2010

EU/2/00/021/001-002

Rabigen SAG2

Liechtenstein

30.4.2010

EU/2/00/021/001-002/IS

Rabigen SAG2

Iceland

5.5.2010

EU/2/00/022/001a-001b,

EU/2/00/022/002a-002b,

EU/2/00/022/003a-003b,

EU/2/022/004a-004b,

EU/2/00/022/005-017

Ibaflin

Liechtenstein

30.6.2010

EU/2/00/022/003-004 a+b&007-008/IS

Ibaflin

Iceland

22.6.2010

EU/2/00/022/001-002 a+b&005-006/IS

Ibaflin

Iceland

22.6.2010

EU/2/00/22/009-017/IS

Ibaflin

Iceland

22.6.2010

EU/2/04/043/001/IS

Equilis StrepE

Iceland

14.4.2010

EU/2/04/047/001/NO-002/NO

Purevax RCPCh FeLV

Norway

24.2.2010

EU/2/04/047/001-002

Purevax RCPCh FeLV

Liechtenstein

28.2.2010

EU/2/04/047/001-002/IS

Purevax RCPCh FeLV

Iceland

15.1.2010

EU/2/04/048/001-002

Purevax RCP FeLV

Liechtenstein

28.2.2010

EU/2/04/048/001-002/IS

Purevax RCP FeLV

Iceland

9.2.2010

EU/2/04/049/001-002

Purevax RCCh

Liechtenstein

28.2.2010

EU/2/04/049/001-002/IS

Purevax RCCh

Iceland

9.2.2010

EU/2/04/051/001-002

Purevax RC

Liechtenstein

28.2.2010

EU/2/04/051/001-002/IS

Purevax RC

Iceland

9.2.2010

EU/2/04/052/001-002/IS

Purevax RCP

Iceland

9.2.2010

EU/2/04/50/001-002/IS

Purevax RCPCh

Iceland

8.2.2010

EU/2/05/053/001-003

Naxcel

Liechtenstein

30.6.2010

EU/2/99/013/001/NO-002/NO

Halocur

Norway

26.4.2010

EU/2/99/013/001-002/IS

Halocur

Iceland

15.3.2010

EU/2/99/017/001/NO-006/NO

Ibraxion

Norway

11.5.2010

EU/2/99/017/001-006/IS

Ibraxion

Iceland

25.5.2010

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2010:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/152/019-020 | Infanrix hexa | Liechtenstein | 30.6.2010 |
| EU/1/00/156/004 | Trizivir | Liechtenstein | 30.6.2010 |
| EU/1/01/172/007 | Kaletra | Liechtenstein | 28.2.2010 |
| EU/1/02/205/003/NO-004/NO | Lumigan | Norway | 12.3.2010 |
| EU/1/02/205/003-004 | Lumigan | Liechtenstein | 28.2.2010 |
| EU/1/02/205/003-004/IS | Lumigan | Iceland | 21.1.2010 |
| EU/1/04/278/010-011 | Levemir | Liechtenstein | 30.4.2010 |
| EU/1/04/306/002-003 | Aloxi | Liechtenstein | 30.6.2010 |
| EU/1/04/306/002-003/IS | Aloxi | Iceland | 11.5.2010 |
| EU/1/05/318/002 | Revatio | Liechtenstein | 28.2.2010 |
| EU/1/05/318/002/IS | Revatio | Iceland | 14.1.2010 |
| EU/1/05/318/002/NO | Revatio | Norway | 18.1.2010 |
| EU/1/05/329/006 | Kiovig | Liechtenstein | 30.6.2010 |
| EU/1/06/334/005 | Evoltra | Liechtenstein | 28.2.2010 |
| EU/1/06/360/013 | Champix | Liechtenstein | 28.2.2010 |
| EU/1/07/384/003/NO-004/NO | Docetaxel Winthrop | Norway | 1.2.2010 |
| EU/1/07/384/003-004 | Docetaxel Winthrop | Liechtenstein | 28.2.2010 |
| EU/1/07/384/005 | Docetaxel Winthrop | Liechtenstein | 30.6.2010 |
| EU/1/07/386/017-018 | Toviaz | Liechtenstein | 28.2.2010 |
| EU/1/07/400/022-024 | Mircera | Liechtenstein | 30.4.2010 |
| EU/1/07/405/021-040 | Rasilez | Liechtenstein | 28.2.2010 |
| EU/1/07/411/021-026/IS | Epoetin alfa Hexal | Iceland | 3.2.2010 |
| EU/1/07/412/021/NO-026/NO | Abseamed | Norway | 13.1.2010 |
| EU/1/07/412/021-026 | Abseamed | Liechtenstein | 28.2.2010 |
| EU/1/07/440/003 | Tyverb | Liechtenstein | 30.6.2010 |
| EU/1/08/444/009-012 | Ratiograstim | Liechtenstein | 28.2.2010 |
| EU/1/08/445/009-014 | Tevagrastim | Liechtenstein | 28.2.2010 |
| EU/1/08/450/009-010 | Biograstim | Liechtenstein | 28.2.2010 |
| EU/1/08/453/002/NO | Prepandrix | Norway | 9.2.2010 |
| EU/1/08/467/002 | Doribax | Liechtenstein | 30.4.2010 |
| EU/1/08/467/002/IS | Doribax | Iceland | 15.6.2010 |
| EU/1/08/494/003-004 | Stelara | Liechtenstein | 30.4.2010 |
| EU/1/08/497/005/NO-008/NO | Nplate | Norway | 2.2.2010 |
| EU/1/08/497/005-008 | Nplate | Liechtenstein | 28.2.2010 |
| EU/1/08/497/005-008/IS | Nplate | Iceland | 22.1.2010 |
| EU/1/09/508/010 | Synflorix | Liechtenstein | 28.2.2010 |
| EU/1/09/525/047-050 | Nimvastid | Liechtenstein | 30.4.2010 |
| EU/1/09/526/002 | Iressa | Liechtenstein | 28.2.2010 |
| EU/1/09/528/002 | Nymusa | Liechtenstein | 30.6.2010 |
| EU/1/09/538/007-008 | Afinitor | Liechtenstein | 30.4.2010 |
| EU/1/09/540/010-016 | Clopidogrel Teva | Liechtenstein | 30.4.2010 |
| EU/1/09/556/010-011 | Clopidogrel Krka | Liechtenstein | 30.4.2010 |
| EU/1/09/557/010 | Clopidogrel Qualimed | Liechtenstein | 30.4.2010 |
| EU/1/09/559/010-016 | Clopidogrel Mylan | Liechtenstein | 30.4.2010 |
| EU/1/95/002/003/NO-004/NO | Taxotere | Norway | 25.1.2010 |
| EU/1/95/002/003-004 | Taxotere | Liechtenstein | 28.2.2010 |
| EU/1/95/002/005 | Taxotere | Liechtenstein | 30.6.2010 |
| EU/1/96/016/005/NO-006/NO | Norvir | Norway | 9.2.2010 |
| EU/1/96/016/005-006 | Norvir | Liechtenstein | 28.2.2010 |
| EU/1/96/016/005-006/IS | Norvir | Iceland | 12.2.2010 |
| EU/1/97/050/028-033 | Sifrol | Liechtenstein | 30.6.2010 |
| EU/1/98/069/012 | Plavix | Liechtenstein | 30.4.2010 |
| EU/1/98/070/012 | Iscover | Liechtenstein | 30.4.2010 |
| EU/1/98/080/002 | Aldara | Liechtenstein | 30.4.2010 |
| EU/1/98/096/024-025 | Temodal | Liechtenstein | 28.2.2010 |
| EU/1/97/051/028-033 | Mirapexin | Liechtenstein | 30.6.2010 |
| EU/2/02/032/002 | Vaxxitek HVT+IBD | Liechtenstein | 30.6.2010 |
| EU/2/04/044/011/NO-013/NO | Aivlosin | Norway | 29.4.2010 |
| EU/2/04/044/011-013 | Aivlosin | Liechtenstein | 28.2.2010 |
| EU/2/04/044/011-013/IS | Aivlosin | Iceland | 7.1.2010 |
| EU/2/06/070/004/IS | Meloxidyl | Iceland | 25.1.2010 |
| EU/2/06/070/005-007 | Meloxidyl | Liechtenstein | 30.4.2010 |
| EU/2/08/083/002-003 | Equioxx | Liechtenstein | 28.2.2010 |
| EU/2/08/083/002-003/IS | Equioxx | Iceland | 11.1.2010 |
| EU/2/08/089/021 | Onsior | Liechtenstein | 28.2.2010 |
| EU/2/08/090/009 | Loxicom | Liechtenstein | 30.4.2010 |
| EU/2/97/004/035-038 | Metacam | Liechtenstein | 28.2.2010 |

EU-Number

Product

Country

Date of authorisation

EU/1/00/152/019-020

Infanrix hexa

Liechtenstein

30.6.2010

EU/1/00/156/004

Trizivir

Liechtenstein

30.6.2010

EU/1/01/172/007

Kaletra

Liechtenstein

28.2.2010

EU/1/02/205/003/NO-004/NO

Lumigan

Norway

12.3.2010

EU/1/02/205/003-004

Lumigan

Liechtenstein

28.2.2010

EU/1/02/205/003-004/IS

Lumigan

Iceland

21.1.2010

EU/1/04/278/010-011

Levemir

Liechtenstein

30.4.2010

EU/1/04/306/002-003

Aloxi

Liechtenstein

30.6.2010

EU/1/04/306/002-003/IS

Aloxi

Iceland

11.5.2010

EU/1/05/318/002

Revatio

Liechtenstein

28.2.2010

EU/1/05/318/002/IS

Revatio

Iceland

14.1.2010

EU/1/05/318/002/NO

Revatio

Norway

18.1.2010

EU/1/05/329/006

Kiovig

Liechtenstein

30.6.2010

EU/1/06/334/005

Evoltra

Liechtenstein

28.2.2010

EU/1/06/360/013

Champix

Liechtenstein

28.2.2010

EU/1/07/384/003/NO-004/NO

Docetaxel Winthrop

Norway

1.2.2010

EU/1/07/384/003-004

Docetaxel Winthrop

Liechtenstein

28.2.2010

EU/1/07/384/005

Docetaxel Winthrop

Liechtenstein

30.6.2010

EU/1/07/386/017-018

Toviaz

Liechtenstein

28.2.2010

EU/1/07/400/022-024

Mircera

Liechtenstein

30.4.2010

EU/1/07/405/021-040

Rasilez

Liechtenstein

28.2.2010

EU/1/07/411/021-026/IS

Epoetin alfa Hexal

Iceland

3.2.2010

EU/1/07/412/021/NO-026/NO

Abseamed

Norway

13.1.2010

EU/1/07/412/021-026

Abseamed

Liechtenstein

28.2.2010

EU/1/07/440/003

Tyverb

Liechtenstein

30.6.2010

EU/1/08/444/009-012

Ratiograstim

Liechtenstein

28.2.2010

EU/1/08/445/009-014

Tevagrastim

Liechtenstein

28.2.2010

EU/1/08/450/009-010

Biograstim

Liechtenstein

28.2.2010

EU/1/08/453/002/NO

Prepandrix

Norway

9.2.2010

EU/1/08/467/002

Doribax

Liechtenstein

30.4.2010

EU/1/08/467/002/IS

Doribax

Iceland

15.6.2010

EU/1/08/494/003-004

Stelara

Liechtenstein

30.4.2010

EU/1/08/497/005/NO-008/NO

Nplate

Norway

2.2.2010

EU/1/08/497/005-008

Nplate

Liechtenstein

28.2.2010

EU/1/08/497/005-008/IS

Nplate

Iceland

22.1.2010

EU/1/09/508/010

Synflorix

Liechtenstein

28.2.2010

EU/1/09/525/047-050

Nimvastid

Liechtenstein

30.4.2010

EU/1/09/526/002

Iressa

Liechtenstein

28.2.2010

EU/1/09/528/002

Nymusa

Liechtenstein

30.6.2010

EU/1/09/538/007-008

Afinitor

Liechtenstein

30.4.2010

EU/1/09/540/010-016

Clopidogrel Teva

Liechtenstein

30.4.2010

EU/1/09/556/010-011

Clopidogrel Krka

Liechtenstein

30.4.2010

EU/1/09/557/010

Clopidogrel Qualimed

Liechtenstein

30.4.2010

EU/1/09/559/010-016

Clopidogrel Mylan

Liechtenstein

30.4.2010

EU/1/95/002/003/NO-004/NO

Taxotere

Norway

25.1.2010

EU/1/95/002/003-004

Taxotere

Liechtenstein

28.2.2010

EU/1/95/002/005

Taxotere

Liechtenstein

30.6.2010

EU/1/96/016/005/NO-006/NO

Norvir

Norway

9.2.2010

EU/1/96/016/005-006

Norvir

Liechtenstein

28.2.2010

EU/1/96/016/005-006/IS

Norvir

Iceland

12.2.2010

EU/1/97/050/028-033

Sifrol

Liechtenstein

30.6.2010

EU/1/98/069/012

Plavix

Liechtenstein

30.4.2010

EU/1/98/070/012

Iscover

Liechtenstein

30.4.2010

EU/1/98/080/002

Aldara

Liechtenstein

30.4.2010

EU/1/98/096/024-025

Temodal

Liechtenstein

28.2.2010

EU/1/97/051/028-033

Mirapexin

Liechtenstein

30.6.2010

EU/2/02/032/002

Vaxxitek HVT+IBD

Liechtenstein

30.6.2010

EU/2/04/044/011/NO-013/NO

Aivlosin

Norway

29.4.2010

EU/2/04/044/011-013

Aivlosin

Liechtenstein

28.2.2010

EU/2/04/044/011-013/IS

Aivlosin

Iceland

7.1.2010

EU/2/06/070/004/IS

Meloxidyl

Iceland

25.1.2010

EU/2/06/070/005-007

Meloxidyl

Liechtenstein

30.4.2010

EU/2/08/083/002-003

Equioxx

Liechtenstein

28.2.2010

EU/2/08/083/002-003/IS

Equioxx

Iceland

11.1.2010

EU/2/08/089/021

Onsior

Liechtenstein

28.2.2010

EU/2/08/090/009

Loxicom

Liechtenstein

30.4.2010

EU/2/97/004/035-038

Metacam

Liechtenstein

28.2.2010

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2010:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/00/148/001-004 | Agenerase | Liechtenstein | 30.6.2010 |
| EU/1/00/148/001-004/IS | Agenerase | Iceland | 29.6.2010 |
| EU/1/06/375/001-033 | Irbesartan BMS | Liechtenstein | 28.2.2010 |
| EU/1/08/471/001-012/IS | Duloxetine
  Boehringer
  Ingelheim | Iceland | 25.6.2010 |
| EU/1/08/471/003-005, 011-012 | Duloxetine
  Boehringer
  Ingelheim | Liechtenstein | 30.6.2010 |
| EU/1/99/113/001-004 | Paxene | Liechtenstein | 28.2.2010 |

EU-Number

Product

Country

Date of withdrawal

EU/1/00/148/001-004

Agenerase

Liechtenstein

30.6.2010

EU/1/00/148/001-004/IS

Agenerase

Iceland

29.6.2010

EU/1/06/375/001-033

Irbesartan BMS

Liechtenstein

28.2.2010

EU/1/08/471/001-012/IS

Duloxetine

Boehringer

Ingelheim

Iceland

25.6.2010

EU/1/08/471/003-005, 011-012

Duloxetine

Boehringer

Ingelheim

Liechtenstein

30.6.2010

EU/1/99/113/001-004

Paxene

Liechtenstein

28.2.2010

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2010:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/09/532/001-007 | Clopidogrel Acino | Liechtenstein | 30.4.2010 |
| EU/1/09/532/001-007/IS | Clopidogrel Acino | Iceland | 30.4.2010 |
| EU/1/09/534/001-007 | Clopidogrel Hexal | Liechtenstein | 30.4.2010 |
| EU/1/09/534/001-007 | Clopidogrel Sandoz | Liechtenstein | 30.4.2010 |
| EU/1/09/534/001-007/IS | Clopidogrel Hexal | Iceland | 30.4.2010 |
| EU/1/09/541/001-007/IS | Clopidogrel ratiopharm GmbH | Iceland | 30.4.2010 |
| EU/1/09/541/001-008 | Clopidogrel ratiopharm GmbH | Liechtenstein | 30.4.2010 |
| EU/1/09/542/001-007 | Clopidogrel 1A Pharma | Liechtenstein | 30.4.2010 |
| EU/1/09/542/001-007/IS | Clopidogrel 1A Pharma | Iceland | 30.4.2010 |
| EU/1/09/547/001-007/IS | Clopidogrel Sandoz | Iceland | 30.4.2010 |
| EU/1/09/548/001-007 | Clopidogrel Acino Pharma GmbH | Liechtenstein | 30.4.2010 |
| EU/1/09/548/001-007/IS | Clopidogrel Acino Pharma GmbH | Iceland | 30.4.2010 |
| EU/1/09/554/001-007/IS | Clopidogrel ratiopharm | Iceland | 30.4.2010 |
| EU/1/09/554/001-008 | Clopidogrel ratiopharm | Liechtenstein | 30.4.2010 |

EU-Number

Product

Country

Date of suspension

EU/1/09/532/001-007

Clopidogrel Acino

Liechtenstein

30.4.2010

EU/1/09/532/001-007/IS

Clopidogrel Acino

Iceland

30.4.2010

EU/1/09/534/001-007

Clopidogrel Hexal

Liechtenstein

30.4.2010

EU/1/09/534/001-007

Clopidogrel Sandoz

Liechtenstein

30.4.2010

EU/1/09/534/001-007/IS

Clopidogrel Hexal

Iceland

30.4.2010

EU/1/09/541/001-007/IS

Clopidogrel ratiopharm GmbH

Iceland

30.4.2010

EU/1/09/541/001-008

Clopidogrel ratiopharm GmbH

Liechtenstein

30.4.2010

EU/1/09/542/001-007

Clopidogrel 1A Pharma

Liechtenstein

30.4.2010

EU/1/09/542/001-007/IS

Clopidogrel 1A Pharma

Iceland

30.4.2010

EU/1/09/547/001-007/IS

Clopidogrel Sandoz

Iceland

30.4.2010

EU/1/09/548/001-007

Clopidogrel Acino Pharma GmbH

Liechtenstein

30.4.2010

EU/1/09/548/001-007/IS

Clopidogrel Acino Pharma GmbH

Iceland

30.4.2010

EU/1/09/554/001-007/IS

Clopidogrel ratiopharm

Iceland

30.4.2010

EU/1/09/554/001-008

Clopidogrel ratiopharm

Liechtenstein

30.4.2010

---